What is the status of the IPO allocation litigation?

JPMorgan Chase's subsidiary, JPMSI, has entered into a Memorandum of Understanding (MOU) to pay $425 million to achieve a unitary settlement of consolidated IPO securities and antitrust class action litigation. This settlement is subject to plaintiff approval, finalization of settlement stipulations, and court approval.

Are there any new significant legal proceedings impacting JPM?

In addition to the IPO allocation litigation, new legal actions have been filed, including state law claims related to JPM's role as indenture trustee for Enron securities, and a shareholder derivative complaint alleging breaches of fiduciary duty by directors and officers. JPM has not yet responded to these new complaints.

What is the company's stance on its overall legal exposure?

JPMorgan Chase believes that the outcome of its currently pending legal actions and proceedings should not have a material adverse effect on its consolidated financial condition, based on its current knowledge, consultation with counsel, and litigation reserves. However, the company acknowledges that the ultimate resolution of these matters could be material to specific periods' results due to inherent uncertainties.

What is the company doing regarding share repurchases?

The Board of Directors approved a new stock repurchase program authorizing up to $8 billion in common shares. In the first quarter of 2006, JPM repurchased approximately 31.8 million shares for $1.3 billion, with $7.9 billion in repurchase capacity remaining under the new program as of March 31, 2006.

JPMORGAN CHASE & CO 10-Q Quarterly Report Q1 FY2006

Summary

JPMorgan Chase & Co. (JPM) filed its quarterly report on Form 10-Q for the period ending March 30, 2006. The filing primarily details ongoing legal proceedings and provides updates on the company's stock repurchase program. Investors should note the significant settlement reached in the IPO allocation litigation, with JPM's subsidiary JPMSI agreeing to pay $425 million to resolve claims related to IPO allocations and antitrust issues. While the company states that the outcome of its various legal matters is not expected to have a material adverse effect on its consolidated financial condition, it acknowledges the inherent uncertainties and the potential for outcomes to be material to specific periods' results.

Key Highlights

1JPMorgan Chase subsidiary JPMSI agreed to a $425 million settlement to resolve consolidated IPO securities and antitrust class action litigation, aiming for a unitary settlement of numerous claims.
2The company is subject to ongoing litigation related to Enron, with new shareholder derivative and state law claims filed, though JPM has not yet responded to all.
3The company's management, including the CEO and CFO, affirmed the effectiveness of disclosure controls and procedures, and no material changes were identified in internal control over financial reporting.
4A new stock repurchase program authorizing up to $8 billion of common shares was approved by the Board of Directors, replacing the previous authorization.
5During the first quarter of 2006, JPM repurchased approximately 31.8 million shares for $1.3 billion under its existing and new repurchase programs.
6The company is undertaking additional risks and uncertainties related to its agreement to acquire consumer, small-business, and middle-market banking businesses from The Bank of New York, including integration challenges and regulatory approvals.
7JPMorgan Chase believes, based on current knowledge and reserves, that the outcome of pending legal actions should not materially adversely affect its consolidated financial condition, but acknowledges potential for material impact on specific periods.

JPMORGAN CHASE & CO Quarterly Report for Q1 Ended Mar 31, 2006

Summary

Key Highlights

Frequently Asked Questions